Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

850 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diagnostic Value of JC Polyomavirus Viruria, Viremia, Serostatus and microRNA Expression in Multiple Sclerosis Patients Undergoing Immunosuppressive Treatment.
Prezioso C, Ciotti M, Brazzini G, Piacentini F, Passerini S, Grimaldi A, Landi D, Nicoletti CG, Zingaropoli MA, Iannetta M, Altieri M, Conte A, Limongi D, Marfia GA, Ciardi MR, Mastroianni CM, Palamara AT, Moens U, Pietropaolo V. Prezioso C, et al. Among authors: grimaldi a. J Clin Med. 2022 Jan 11;11(2):347. doi: 10.3390/jcm11020347. J Clin Med. 2022. PMID: 35054041 Free PMC article.
Influence of Previous Disease-Modifying Drug Exposure on T-Lymphocyte Dynamic in Patients With Multiple Sclerosis Treated With Ocrelizumab.
Landi D, Grimaldi A, Bovis F, Ponzano M, Fantozzi R, Buttari F, Signoriello E, Lus G, Lucchini M, Mirabella M, Cellerino M, Inglese M, Cola G, Nicoletti CG, Mataluni G, Centonze D, Marfia GA. Landi D, et al. Among authors: grimaldi a. Neurol Neuroimmunol Neuroinflamm. 2022 Mar 10;9(3):e1157. doi: 10.1212/NXI.0000000000001157. Print 2022 May. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 35273036 Free PMC article.
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis.
Landi D, Bovis F, Grimaldi A, Annovazzi PO, Bertolotto A, Bianchi A, Borriello G, Brescia Morra V, Bucello S, Buscarinu MC, Caleri F, Capobianco M, Capra R, Cellerino M, Centonze D, Cerqua R, Chisari CG, Clerico M, Cocco E, Cola G, Cordioli C, Curti E, d'Ambrosio A, D'Amico E, De Luca G, Di Filippo M, Di Lemme S, Fantozzi R, Ferraro D, Ferraro E, Gallo A, Gasperini C, Granella F, Inglese M, Lanzillo R, Lorefice L, Lus G, Malucchi S, Margoni M, Mataluni G, Mirabella M, Moiola L, Nicoletti CG, Nociti V, Patti F, Pinardi F, Portaccio E, Pozzilli C, Ragonese P, Rasia S, Salemi G, Signoriello E, Vitetta F, Totaro R, Sormani MP, Amato MP, Marfia GA. Landi D, et al. Among authors: grimaldi a. J Neurol Neurosurg Psychiatry. 2022 Sep 30:jnnp-2022-329657. doi: 10.1136/jnnp-2022-329657. Online ahead of print. J Neurol Neurosurg Psychiatry. 2022. PMID: 36180219
KCa3.1 channels are involved in the infiltrative behavior of glioblastoma in vivo.
D'Alessandro G, Catalano M, Sciaccaluga M, Chece G, Cipriani R, Rosito M, Grimaldi A, Lauro C, Cantore G, Santoro A, Fioretti B, Franciolini F, Wulff H, Limatola C. D'Alessandro G, et al. Among authors: grimaldi a. Cell Death Dis. 2013 Aug 15;4(8):e773. doi: 10.1038/cddis.2013.279. Cell Death Dis. 2013. PMID: 23949222 Free PMC article.
KCa3.1 channel inhibition sensitizes malignant gliomas to temozolomide treatment.
D'Alessandro G, Grimaldi A, Chece G, Porzia A, Esposito V, Santoro A, Salvati M, Mainiero F, Ragozzino D, Di Angelantonio S, Wulff H, Catalano M, Limatola C. D'Alessandro G, et al. Among authors: grimaldi a. Oncotarget. 2016 May 24;7(21):30781-96. doi: 10.18632/oncotarget.8761. Oncotarget. 2016. PMID: 27096953 Free PMC article.
850 results